Edronax, known generically as reboxetine, is a type of antidepressant medication primarily used in the treatment of major depressive disorder (MDD). It functions as a selective norepinephrine reuptake inhibitor (NRI), which means it specifically targets and increases the levels of norepinephrine in the brain, a neurotransmitter associated with mood and alertness. Unlike many other antidepressants that affect serotonin levels, Edronax focuses on norepinephrine, offering an alternative for patients who may not respond well to or experience side effects from other types of antidepressants. It is typically administered in tablet form and prescribed by a healthcare professional, who will adjust the dosage based on the patient's response to the medication. As with any antidepressant, it may take several weeks to observe the full benefits of Edronax, and it is important for patients to communicate with their healthcare provider about their progress and any side effects they experience.